Reuters logo
BRIEF-Bristol-Myers' Nivolumab study reaches limit, suspends recruitment - Clinicaltrials.gov
January 6, 2017 / 3:38 PM / 9 months ago

BRIEF-Bristol-Myers' Nivolumab study reaches limit, suspends recruitment - Clinicaltrials.gov

Jan 6 (Reuters) - Clinicaltrials.gov

* Bristol-Myers’ study of Nivolumab with, without Ipilimumab treating patients with Metastatic Sarcoma that can’t be removed suspended recruitment - Clinicaltrials.gov

* Bristol-Myers' Nivolumab study suspended per complete sheet, pre-registration limit reached - Clinicaltrials.gov Source (bit.ly/2iQj5Gj) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below